Generative AI is rapidly gaining traction across many industries and modern cloud-based ecosystems, including pharmaceutical life sciences. However, there are a number of unique benefits and risks, especially given the highly regulated environment and potential for long-term impact on millions of lives.
In this session, we explore how using generative AI and machine learning as core components of your business has the potential to drive the next generation of drug development and usher in a new wave of exciting outcomes for patients and providers alike.
Watch the video